Differences in Frequency of Visits to Pediatric Primary Care Practices and Emergency Departments by Body Mass Index

Olga Kovalerchik1, Emily Powers2, Margaret L Holland3

  • 1Department of Emergency Medicine, Yale University School of Medicine (O Kovalerchik and ML Langhan), New Haven, Conn.

Academic Pediatrics
|January 7, 2020
PubMed

Insights

Children with higher body mass index (BMI) categories utilize primary care more and have higher hospitalization risks. Further research is needed to understand healthcare access and weight management.

Area of Science:

  • Pediatric Health
  • Public Health Research
  • Healthcare Utilization Studies

Background:

  • Body Mass Index (BMI) categories are critical indicators of child health.
  • Understanding healthcare utilization patterns across different BMI categories is essential for targeted interventions.
  • Previous research has highlighted disparities in healthcare access and outcomes based on weight status.

Purpose of the Study:

  • To investigate how body mass index (BMI) categories influence healthcare utilization among children.
  • To identify specific healthcare settings where utilization differs based on BMI.
  • To inform the development of targeted interventions for pediatric weight management.

Main Methods:

  • Retrospective analysis of electronic health records for children aged 3-17 years.
  • Inclusion of data from over 40 pediatric practices within a Northeastern health system.
  • Comparison of healthcare utilization (primary care, emergency department visits, hospitalizations) across normal BMI, overweight, obesity, and severe obesity categories.

Main Results:

  • Prevalence of overweight, obesity, and severe obesity was 16.3%, 12.4%, and 5.7% respectively.
  • Children outside the normal BMI range had increased primary care visits.
  • Higher BMI categories were associated with increased hospitalization risk, but not consistently with emergency department visit acuity.

Conclusions:

  • Childhood BMI categories significantly correlate with variations in healthcare utilization, including primary care and hospitalizations.
  • Further research is warranted to explore factors influencing these utilization differences, such as weight bias.
  • The role of non-primary care settings in pediatric weight management requires additional investigation.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
170
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
209
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
202
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
193
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
191